Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Michal Canetti; Noam Barda; Mayan Gilboa; Victoria Indenbaum; Michal Mandelboim; Tal Gonen; Keren Asraf; Yael Weiss-Ottolenghi; Sharon Amit; Ram Doolman; Ella Mendelson; Dror Harats; Laurence S. Freedman; Yitshak Kreiss; Yaniv Lustig; Gili Regev-Yochay

doi:10.1038/s41467-023-37338-7

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S. Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay

Ben-Gurion University of the Negev, Tel Aviv University

Research output: Contribution to journal › Comment/debate

Abstract

The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

Original language	American English
Article number	1593
Journal	Nature Communications
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41467-023-37338-7
State	Published - 1 Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

General Chemistry
General Biochemistry,Genetics and Molecular Biology
General Physics and Astronomy

Access to Document

10.1038/s41467-023-37338-7

Cite this

Canetti, M., Barda, N., Gilboa, M., Indenbaum, V., Mandelboim, M., Gonen, T., Asraf, K., Weiss-Ottolenghi, Y., Amit, S., Doolman, R., Mendelson, E., Harats, D., Freedman, L. S., Kreiss, Y., Lustig, Y., & Regev-Yochay, G. (2023). Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2). Nature Communications, 14(1), Article 1593. https://doi.org/10.1038/s41467-023-37338-7

@article{f27b454efc4a4cf9866302b731541fc3,

title = "Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)",

abstract = "The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.",

author = "Michal Canetti and Noam Barda and Mayan Gilboa and Victoria Indenbaum and Michal Mandelboim and Tal Gonen and Keren Asraf and Yael Weiss-Ottolenghi and Sharon Amit and Ram Doolman and Ella Mendelson and Dror Harats and Freedman, \{Laurence S.\} and Yitshak Kreiss and Yaniv Lustig and Gili Regev-Yochay",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

day = "1",

doi = "10.1038/s41467-023-37338-7",

language = "American English",

volume = "14",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

Canetti, M, Barda, N, Gilboa, M, Indenbaum, V, Mandelboim, M, Gonen, T, Asraf, K, Weiss-Ottolenghi, Y, Amit, S, Doolman, R, Mendelson, E, Harats, D, Freedman, LS, Kreiss, Y, Lustig, Y & Regev-Yochay, G 2023, 'Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)', Nature Communications, vol. 14, no. 1, 1593. https://doi.org/10.1038/s41467-023-37338-7

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2). / Canetti, Michal; Barda, Noam; Gilboa, Mayan et al.
In: Nature Communications, Vol. 14, No. 1, 1593, 01.12.2023.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction

T2 - Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

AU - Canetti, Michal

AU - Barda, Noam

AU - Gilboa, Mayan

AU - Indenbaum, Victoria

AU - Mandelboim, Michal

AU - Gonen, Tal

AU - Asraf, Keren

AU - Weiss-Ottolenghi, Yael

AU - Amit, Sharon

AU - Doolman, Ram

AU - Mendelson, Ella

AU - Harats, Dror

AU - Freedman, Laurence S.

AU - Kreiss, Yitshak

AU - Lustig, Yaniv

AU - Regev-Yochay, Gili

PY - 2023/12/1

Y1 - 2023/12/1

N2 - The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

AB - The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

UR - http://www.scopus.com/inward/record.url?scp=85150810911&partnerID=8YFLogxK

U2 - 10.1038/s41467-023-37338-7

DO - 10.1038/s41467-023-37338-7

M3 - Comment/debate

C2 - 36949080

SN - 2041-1723

VL - 14

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 1593

ER -

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up (Nature Communications, (2022), 13, 1, (7711), 10.1038/s41467-022-35480-2)

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this